Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("5q- syndrome")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 63

  • Page / 3

Selection :

  • and

Gene expression profiling of CD34+ cells in patients with the 5q-syndromeBOULTWOOD, Jacqueline; PELLAGATTI, Andrea; CAZZOLA, Mario et al.British journal of haematology. 2007, Vol 139, Num 4, pp 578-589, issn 0007-1048, 12 p.Article

The 5q syndrome : a single-institution study of 43 consecutive patientsMATHEW, P; TEFFERI, A; DEWALD, G. W et al.Blood. 1993, Vol 81, Num 4, pp 1040-1045, issn 0006-4971Article

Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletionDEFINA, Marzia; RONDONI, Michela; GOZZETTI, Alessandro et al.British journal of haematology. 2010, Vol 148, Num 3, pp 483-484, issn 0007-1048, 2 p.Article

Haploinsufficiency of RPS14 in 5q-syndrome is associated with deregulation of ribosomal-and translation-related genesPELLAGATTI, Andrea; HELLSTRÖM-LINDBERG, Eva; WAINSCOAT, James S et al.British journal of haematology. 2008, Vol 142, Num 1, pp 57-64, issn 0007-1048, 8 p.Article

Deletion of c-fms sequences in the 5q-syndromeBARTRAM, C. R; BÖHLKE, J. V; ADOLPH, S et al.Leukemia. 1987, Vol 1, Num 2, pp 146-149, issn 0887-6924Article

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5qMALLO, M; CERVERA, J; BLUM, S et al.Leukemia. 2011, Vol 25, Num 1, pp 110-120, issn 0887-6924, 11 p.Article

Unimpaired terminal erythroid differentiation and preserved enucleation capacity in myelodysplastic 5q(del) clones: a single cell studyGARDERET, Laurent; KOBARI, Ladan; MAZURIER, Christelle et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 398-405, issn 0390-6078, 8 p.Article

Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancerEBERT, B. L.Leukemia. 2009, Vol 23, Num 7, pp 1252-1256, issn 0887-6924, 5 p.Article

Common deleted genes in the 5q-syndrome : thrombocytopenia and reduced erythroid colony formation in SPARC null miceLEHMANN, S; O'KELLY, J; RAYNAUD, S et al.Leukemia. 2007, Vol 21, Num 9, pp 1931-1936, issn 0887-6924, 6 p.Article

Utilisation du lénalidomide dans les syndromes myélodysplasiques del(5q)ADES, L.Correspondances en onco-hématologie. 2014, Vol 9, Num 2, pp 76-80, issn 1954-4820, 5 p.Article

Van-den Berghe's 5q-syndrome in 2008MOHAMEDALI, Azim; MUFTI, Ghulam J.British journal of haematology. 2009, Vol 144, Num 2, pp 157-168, issn 0007-1048, 12 p.Article

Molecular pathogenesis in Diamond-Blackfan anemia : PIH: Recent advances in inherited bone marrow failure syndromesITO, Etsuro; KONNO, Yuki; TOKI, Tsutomu et al.International journal of hematology. 2010, Vol 92, Num 3, pp 413-418, issn 0925-5710, 6 p.Article

The JAK2 V617F mutation identifies a subgroup of MD5 patients with isolated deletion 5q and a proliferative bone marrowINGRAM, W; LEA, N. C; ARNO, M. J et al.Leukemia. 2006, Vol 20, Num 7, pp 1319-1321, issn 0887-6924, 3 p.Article

5q-syndrome : New Treatment Strategy of the Myelodysplastic SyndromesBOULTWOOD, Jacqueline; PELLAGATTI, Andrea; WAINSCOAT, James S et al.Current pharmaceutical design (Print). 2012, Vol 18, Num 22, pp 3180-3183, issn 1381-6128, 4 p.Article

Advances in the 5q- syndromeBOULTWOOD, Jacqueline; PELLAGATTI, Andrea; MCKENZIE, Andrew N. J et al.Blood. 2010, Vol 116, Num 26, pp 5803-5811, issn 0006-4971, 9 p.Article

Erythropoïèse des syndromes myélodysplasiques: cas du syndrome 5qVINCENT, Laure.Hématologie (Montrouge). 2010, Vol 16, pp 17-20, issn 1264-7527, 4 p., SUP3Conference Paper

Mosasic 46,XY/92,XXYY,del(5)(q13 q34) in an adult lymphoblastic leukemiaVALTAT, C; UETTWILLER, F; FLORI, E et al.Leukemia research. 1991, Vol 15, Num 7, pp 651-653, issn 0145-2126Article

Acquired EVI1 rearrangement involved in the transformation from 5q- syndrome to pre-B lymphocytic leukemia in a Chinese patientDANDAN LIU; SUNING CHEN; JINLAN PAN et al.International journal of hematology. 2012, Vol 96, Num 6, pp 806-809, issn 0925-5710, 4 p.Article

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arraysLI WANG; FIDLER, Carrie; WAINSCOAT, James S et al.Haematologica (Roma). 2008, Vol 93, Num 7, pp 994-1000, issn 0390-6078, 7 p.Article

Narrowing and genomic annotation of the commonly deleted region of the 5q- syndromeBOULTWOOD, Jacqueline; FIDLER, Carrie; WAINSCOAT, James S et al.Blood. 2002, Vol 99, Num 12, pp 4638-4641, issn 0006-4971Article

Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic SyndromesGIAGOUNIDIS, Aristoteles A. N.Seminars in hematology. 2012, Vol 49, Num 4, pp 312-322, issn 0037-1963, 11 p.Article

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndromeLOPEZ-VILLAR, O; GARCIA, J. L; HERNANDEZ-RIVAS, J. M et al.Leukemia. 2009, Vol 23, Num 4, pp 664-672, issn 0887-6924, 9 p.Article

Leukemic transformation in patients with the 5q-alteration: analysis of the behavior of the 5q-clones in preleukemic to leukemic phasesBENITEZ, J; MARTINEZ FREJO, C; TOLEDO, C et al.Cancer genetics and cytogenetics. 1987, Vol 26, Num 2, pp 199-207, issn 0165-4608Article

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblastsYIP, B. H; PELLAGATTI, A; WAINSCOAT, J. S et al.Leukemia. 2012, Vol 26, Num 9, pp 2154-2158, issn 0887-6924, 5 p.Article

Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletionXIMERI, Maria; GALANOPOULOS, Athanasios; HATZIMICHAEL, Eleftheria et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 406-414, issn 0390-6078, 9 p.Article

  • Page / 3